Suppr超能文献

异常的Rheb介导的mTORC1激活和Pten单倍体不足是协同致癌事件。

Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events.

作者信息

Nardella Caterina, Chen Zhenbang, Salmena Leonardo, Carracedo Arkaitz, Alimonti Andrea, Egia Ainara, Carver Brett, Gerald William, Cordon-Cardo Carlos, Pandolfi Pier Paolo

机构信息

Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.

出版信息

Genes Dev. 2008 Aug 15;22(16):2172-7. doi: 10.1101/gad.1699608.

Abstract

The mammalian target of rapamycin (mTOR) represents a critical signaling crossroad where pathways commonly disrupted in cancer converge. We report here that Rheb GTPase, the upstream activator of the mTOR complex 1 (mTORC1) is amplified in human prostate cancers. We demonstrate that Rheb overexpression promotes hyperplasia and a low-grade neoplastic phenotype in the mouse prostate while eliciting a concomitant senescence response and a negative feedback loop limiting Akt activation. Importantly, we show that Pten haploinsufficiency cooperates with Rheb overexpression to markedly promote prostate tumorigenesis. We conclude that Rheb acts as a proto-oncogene in the appropriate genetic milieu and signaling context.

摘要

雷帕霉素的哺乳动物靶点(mTOR)是一个关键的信号交叉点,癌症中常见的信号通路在此汇聚。我们在此报告,mTOR复合物1(mTORC1)的上游激活因子Rheb GTP酶在人类前列腺癌中发生扩增。我们证明,Rheb过表达促进小鼠前列腺增生和低级别肿瘤表型,同时引发伴随的衰老反应和限制Akt激活的负反馈回路。重要的是,我们表明Pten单倍体不足与Rheb过表达协同作用,显著促进前列腺肿瘤发生。我们得出结论,在适当的遗传环境和信号背景下,Rheb作为原癌基因发挥作用。

相似文献

2
Tumorigenic activity and therapeutic inhibition of Rheb GTPase.
Genes Dev. 2008 Aug 15;22(16):2178-88. doi: 10.1101/gad.1690808.
4
[Rheb-mTOR signaling pathway involved in tumor formation].
Tanpakushitsu Kakusan Koso. 2010 Jan;55(1):11-7.
5
Amino acid regulation of TOR complex 1.
Am J Physiol Endocrinol Metab. 2009 Apr;296(4):E592-602. doi: 10.1152/ajpendo.90645.2008. Epub 2008 Sep 2.
8
PTEN deficiency is fully penetrant for prostate adenocarcinoma in C57BL/6 mice via mTOR-dependent growth.
Am J Pathol. 2009 May;174(5):1869-79. doi: 10.2353/ajpath.2009.080055.
9
Re-evaluating the roles of proposed modulators of mammalian target of rapamycin complex 1 (mTORC1) signaling.
J Biol Chem. 2008 Nov 7;283(45):30482-92. doi: 10.1074/jbc.M803348200. Epub 2008 Aug 1.
10
Rheb/mTORC1 signaling promotes kidney fibroblast activation and fibrosis.
J Am Soc Nephrol. 2013 Jun;24(7):1114-26. doi: 10.1681/ASN.2012050476. Epub 2013 May 9.

引用本文的文献

2
5
Blocking the Farnesyl Pocket of PDEδ Reduces Rheb-Dependent mTORC1 Activation and Survival of Cells.
Front Pharmacol. 2022 Jun 23;13:912688. doi: 10.3389/fphar.2022.912688. eCollection 2022.
7
Contemporary biomedical engineering perspective on volitional evolution for human radiotolerance enhancement beyond low-earth orbit.
Synth Biol (Oxf). 2021 Sep 2;6(1):ysab023. doi: 10.1093/synbio/ysab023. eCollection 2021.
8
The Paradoxical Role of Cellular Senescence in Cancer.
Front Cell Dev Biol. 2021 Aug 12;9:722205. doi: 10.3389/fcell.2021.722205. eCollection 2021.
9
Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention.
Pharmaceutics. 2021 Aug 3;13(8):1195. doi: 10.3390/pharmaceutics13081195.
10
LKB1-PTEN axis controls Th1 and Th17 cell differentiation via regulating mTORC1.
J Mol Med (Berl). 2021 Aug;99(8):1139-1150. doi: 10.1007/s00109-021-02090-2. Epub 2021 May 18.

本文引用的文献

1
Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38.
Science. 2007 Nov 9;318(5852):977-80. doi: 10.1126/science.1147379.
2
Breaking news: high-speed race ends in arrest--how oncogenes induce senescence.
Trends Cell Biol. 2007 Nov;17(11):529-36. doi: 10.1016/j.tcb.2007.07.012. Epub 2007 Nov 5.
3
Defining the role of mTOR in cancer.
Cancer Cell. 2007 Jul;12(1):9-22. doi: 10.1016/j.ccr.2007.05.008.
4
AKT/PKB signaling: navigating downstream.
Cell. 2007 Jun 29;129(7):1261-74. doi: 10.1016/j.cell.2007.06.009.
5
mTOR and cancer therapy.
Oncogene. 2006 Oct 16;25(48):6436-46. doi: 10.1038/sj.onc.1209886.
6
TOR signaling in growth and metabolism.
Cell. 2006 Feb 10;124(3):471-84. doi: 10.1016/j.cell.2006.01.016.
7
Akt-regulated pathways in prostate cancer.
Oncogene. 2005 Nov 14;24(50):7465-74. doi: 10.1038/sj.onc.1209096.
9
Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2.
Genes Dev. 2005 Aug 1;19(15):1773-8. doi: 10.1101/gad.1314605. Epub 2005 Jul 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验